Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Amneal Pharmaceuticals, Inc. - Class A Common Stock (NQ:AMRX)

12.52 UNCHANGED

Official Closing Price Updated: 1:15 PM EST, Nov 28, 2025 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	1,559,923
Open	12.51
Bid (Size)	12.52 (700)
Ask (Size)	12.61 (100)
Prev. Close	12.52
Today's Range	12.41 - 12.68
52wk Range	6.685 - 12.68
Shares Outstanding	1,000
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Is Amneal Stock a Buy After Investment Firm Westshore Wealth Bought Over 1 Million Shares? ↗

November 28, 2025

The pharmaceutical company has experienced sales growth over the past five years.

Via The Motley Fool

Natera, Amneal, Chemed, The Pennant Group, and HCA Healthcare Shares Are Soaring, What You Need To Know

November 21, 2025

A number of stocks jumped in the afternoon session after comments from a key Federal Reserve official bolstered hopes for an interest rate cut. New York Federal Reserve President John Williams stated...

Via StockStory

Performance

YTD	+61.3%	+61.3%
1 Month	+20.0%	+20.0%
3 Month	+31.0%	+31.0%
6 Month	+71.0%	+71.0%
1 Year	+51.4%	+51.4%

More News

Amneal EVP Sells $1.6 Million in Shares as Stock Trades Near Multi-Year Highs ↗

November 21, 2025

Via The Motley Fool

Earnings Scheduled For October 30, 2025 ↗

October 30, 2025

Via Benzinga

Unpacking Q3 Earnings: Amneal (NASDAQ:AMRX) In The Context Of Other Generic Pharmaceuticals Stocks

November 19, 2025

Via StockStory

3 Russell 2000 Stocks with Warning Signs

November 13, 2025

Via StockStory

Amneal Receives U.S. FDA Approval for Iohexol Injection

November 13, 2025

From Amneal Pharmaceuticals LLC

Via GlobeNewswire

3 Stocks Under $50 We Steer Clear Of

November 11, 2025

Via StockStory

Pfizer, Amneal, Jazz Pharmaceuticals, BD, and DaVita Shares Skyrocket, What You Need To Know

November 11, 2025

Via StockStory

3 Value Stocks We Find Risky

November 09, 2025

Via StockStory

Why Amneal (AMRX) Stock Is Up Today

October 31, 2025

Via StockStory

Amneal Pharmaceuticals Inc (NASDAQ:AMRX) Q3 2025 Earnings: EPS Beats Estimates, Stock Surges on Raised Guidance ↗

October 30, 2025

Via Chartmill

Amneal (NASDAQ:AMRX) Beats Q3 Sales Expectations, Stock Soars

October 30, 2025

Via StockStory

Amneal Reports Third Quarter 2025 Financial Results

October 30, 2025

From Amneal Pharmaceuticals LLC

Via GlobeNewswire

Amneal Receives U.S. FDA Tentative Approval for Beclomethasone Dipropionate HFA Inhalation Aerosol

October 29, 2025

From Amneal Pharmaceuticals LLC

Via GlobeNewswire

Amneal Earnings: What To Look For From AMRX

October 28, 2025

Via StockStory

Amneal Launches Brekiya® – the First and Only DHE Autoinjector for Adults with Migraine With or Without Aura and Cluster Headaches

October 27, 2025

From Amneal Pharmaceuticals LLC

Via GlobeNewswire

3 Cash-Producing Stocks with Questionable Fundamentals

October 27, 2025

Via StockStory

3 of Wall Street’s Favorite Stocks We Find Risky

October 14, 2025

Via StockStory

Teva, Viatris On Investor Watch As White House Spares Generic Drugs From Tariffs ↗

October 09, 2025

Via Benzinga

1 Small-Cap Stock with Competitive Advantages and 2 We Turn Down

October 09, 2025

Via StockStory

Kashiv Biosciences Announces Submission of Biologics License Application to U.S. FDA and Acceptance of Market Authorization Application by European Medicines Agency for ADL-018, a Proposed Biosimilar to XOLAIR® (omalizumab)

October 06, 2025

From Kashiv BioSciences, LLC and Amneal Pharmaceuticals, Inc. and Alvotech and Advanz Pharma

Via Business Wire

3 Lesser-Known Healthcare Names With Major Upside in Store ↗

October 02, 2025

Via MarketBeat

Amneal to Report Third Quarter 2025 Results on October 30, 2025

September 30, 2025

From Amneal Pharmaceuticals LLC

Via GlobeNewswire

Amneal Announces BLA Submission of Biosimilar Candidate to XOLAIR® (omalizumab)

September 26, 2025

From Amneal Pharmaceuticals LLC

Via GlobeNewswire

Frequently Asked Questions

Is Amneal Pharmaceuticals, Inc. - Class A Common Stock publicly traded?

Yes, Amneal Pharmaceuticals, Inc. - Class A Common Stock is publicly traded.

What exchange does Amneal Pharmaceuticals, Inc. - Class A Common Stock trade on?

Amneal Pharmaceuticals, Inc. - Class A Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Amneal Pharmaceuticals, Inc. - Class A Common Stock?

The ticker symbol for Amneal Pharmaceuticals, Inc. - Class A Common Stock is AMRX on the Nasdaq Stock Market

What is the current price of Amneal Pharmaceuticals, Inc. - Class A Common Stock?

The current price of Amneal Pharmaceuticals, Inc. - Class A Common Stock is 12.52

When was Amneal Pharmaceuticals, Inc. - Class A Common Stock last traded?

The last trade of Amneal Pharmaceuticals, Inc. - Class A Common Stock was at 11/28/25 01:15 PM ET

What is the market capitalization of Amneal Pharmaceuticals, Inc. - Class A Common Stock?

The market capitalization of Amneal Pharmaceuticals, Inc. - Class A Common Stock is 12.52K

How many shares of Amneal Pharmaceuticals, Inc. - Class A Common Stock are outstanding?

Amneal Pharmaceuticals, Inc. - Class A Common Stock has 13K shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.